Cargando…

Correction to: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Chen, Qian, Zhou, Xiao-Wei, Zhang, Ai-Jun, He, Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040239/ https://www.ncbi.nlm.nih.gov/pubmed/33845876 http://dx.doi.org/10.1186/s13046-021-01924-8

Ejemplares similares

ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
por: Chen, Qian, et al.
Publicado: (2021)

Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

Correction: Actin Cytoskeleton Regulates Hippo Signaling
por: Reddy, Pradeep, et al.
Publicado: (2013)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
por: Liu, Yuchen, et al.
Publicado: (2020)

KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling
por: Tong, Rongliang, et al.
Publicado: (2017)

The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma
por: Xie, Peiyi, et al.
Publicado: (2021)

Correction: The ACTN3 R577X Polymorphism across Three Groups of Elite Male European Athletes
Publicado: (2014)

Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells
por: Wang, Neng, et al.
Publicado: (2022)

Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014)

Correction: Salvador–Warts–Hippo pathway regulates sensory organ development via caspase-dependent nonapoptotic signaling
por: Wang, Lan-Hsin, et al.
Publicado: (2019)

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma
por: Zhao, Xiaofang, et al.
Publicado: (2020)

Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression
por: Hu, Ming-Hua, et al.
Publicado: (2021)

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2019)

Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signaling
por: Zhang, Xiaodong, et al.
Publicado: (2017)

Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
por: Rahmat, Muhammad Bakhait, et al.
Publicado: (2019)

Correction: Altered Ca(2+) Kinetics Associated with α-Actinin-3 Deficiency May Explain Positive Selection for ACTN3 Null Allele in Human Evolution
Publicado: (2015)

Author Correction: AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition
por: Zhang, Kai-li, et al.
Publicado: (2020)

Change of guard at ACTN
por: Hoke, Ahmet
Publicado: (2023)

Correction to: Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro
por: Rong, Minhua, et al.
Publicado: (2020)

Correction to: Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase
por: Liu, Jingxian, et al.
Publicado: (2021)

Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway
por: Wang, Haina, et al.
Publicado: (2021)

A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma
por: Shen, Lili, et al.
Publicado: (2016)

The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
por: Li, Xu, et al.
Publicado: (2022)

RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma
por: Lin, Cheng, et al.
Publicado: (2022)

α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Hippo-Yes-Associated Protein Signaling Pathway
por: Chen, Tongqing, et al.
Publicado: (2022)

Correction: CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2023)

Correction: Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway
Publicado: (2020)

Correction: Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signaling in breast cancer
por: Shen, Jie, et al.
Publicado: (2023)

Correction to: A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling
por: Zheng, Xiao, et al.
Publicado: (2021)

Correction: A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma
por: Xiong, Fei
Publicado: (2015)

Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade
por: Jia, Jiaoyuan, et al.
Publicado: (2017)

Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959
por: Davidi, Shiri, et al.
Publicado: (2023)

MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
por: Guan, Lei, et al.
Publicado: (2019)

High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma
por: Xie, Guo-feng, et al.
Publicado: (2020)

Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2023)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Molecular Classification of Hepatocellular Carcinoma Using Wnt–Hippo Signaling Pathway-Related Genes
por: Chang, Ya-Sian, et al.
Publicado: (2022)

Author Correction: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
por: Pan, Hongming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2prp00a684sgc10hssa2hptioe